GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dr Wu Skincare Co Ltd (ROCO:6523) » Definitions » Debt-to-EBITDA

Dr Wu Skincare Co (ROCO:6523) Debt-to-EBITDA : 0.00 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Dr Wu Skincare Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dr Wu Skincare Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$3 Mil. Dr Wu Skincare Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$0 Mil. Dr Wu Skincare Co's annualized EBITDA for the quarter that ended in Mar. 2024 was NT$821 Mil. Dr Wu Skincare Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Dr Wu Skincare Co's Debt-to-EBITDA or its related term are showing as below:

During the past 12 years, the highest Debt-to-EBITDA Ratio of Dr Wu Skincare Co was 0.17. The lowest was 0.00. And the median was 0.04.

ROCO:6523's Debt-to-EBITDA is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 2.125
* Ranked among companies with meaningful Debt-to-EBITDA only.

Dr Wu Skincare Co Debt-to-EBITDA Historical Data

The historical data trend for Dr Wu Skincare Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Wu Skincare Co Debt-to-EBITDA Chart

Dr Wu Skincare Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.04 0.07 0.04 0.01

Dr Wu Skincare Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.01 0.01 -

Competitive Comparison of Dr Wu Skincare Co's Debt-to-EBITDA

For the Household & Personal Products subindustry, Dr Wu Skincare Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Wu Skincare Co's Debt-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Wu Skincare Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dr Wu Skincare Co's Debt-to-EBITDA falls into.



Dr Wu Skincare Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dr Wu Skincare Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.047 + 0) / 535.457
=0.01

Dr Wu Skincare Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.532 + 0) / 821.084
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Dr Wu Skincare Co  (ROCO:6523) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Dr Wu Skincare Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Dr Wu Skincare Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Wu Skincare Co (ROCO:6523) Business Description

Traded in Other Exchanges
N/A
Address
Nanjing East Road, 13th Floor., No. 70, Section. 3, Zhongshan District, Taipei, TWN, 100
Dr Wu Skincare Co Ltd is a Taiwan based company primarily engaged in the research, development, production, wholesale and retail of cosmetics. It principally manufactures and sells cosmetics. The company offers products such as cosmetic masks, lotions, eye care products, moisturizers and others. The group derives its revenue primarily from the sales of private label care products. It sells the products in Taiwan and internationally, of which majority of the revenue is derived from the sales made in Taiwan.

Dr Wu Skincare Co (ROCO:6523) Headlines

No Headlines